Your account is not claimed yet. You can sign up with ORCID to claim your account.

Katia Scotlandi

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 45

Top Venues

Cancers

Communications biology

International journal of molecular sciences

Cells

IRCCS Istituto Ortopedico Rizzoli

This page only lists publications with an associated author ORCID identifier.

Affiliation History

IRCCS Istituto Ortopedico Rizzoli Feb 1o 2019

Italy

Director FF Laboratory of Experimental Oncology

Publications

Halle J Mallard, Shibiao Wan, Prakriti Nidhi, Yvan D Hanscom-Trofy, Bhopal C Mohapatra, Nicholas T Woods, Jose Antonio Lopez-Guerrero, Antonio Llombart-Bosch, Isidro Machado, Katia Scotlandi, Natasha F Kreiling, Megan C Perry, Sameer Mirza, Donald W Coulter, Vimla Band, Hamid Band, Gargi Ghosal
USP1 expression driven by EWS::FLI1 transcription factor stabilizes Survivin and mitigates replication stress in Ewing sarcoma. Molecular cancer research : MCR (2023)
Sara Salucci, Alberto Bavelloni, Anna Bartoletti Stella, Francesco Fabbri, Ivan Vannini, Manuela Piazzi, Karyna Volkava, Katia Scotlandi, Giovanni Martinelli, Irene Faenza, William L Blalock
The Cytotoxic Effect of Curcumin in Rhabdomyosarcoma Is Associated with the Modulation of AMPK, AKT/mTOR, STAT, and p53 Signaling. Nutrients 15 (3) (2023)
Federica Scotto di Carlo, Sharon Russo, Francesc Muyas, Maria Mangini, Lorenza Garribba, Laura Pazzaglia, Rita Genesio, Flavia Biamonte, Anna Chiara De Luca, Stefano Santaguida, Katia Scotlandi, Isidro Cortes-Ciriano, Fernando Gianfrancesco
Profilin 1 deficiency drives mitotic defects and reduces genome stability. Communications biology 6 (1) (2023)
Maria Cristina Manara, Cristina Manferdini, Camilla Cristalli, Marianna Carrabotta, Spartaco Santi, Alessandra De Feo, Giulia Caldoni, Michela Pasello, Lorena Landuzzi, Pier-Luigi Lollini, Francesca Salamanna, Sabrina Dominici, Valentina Fiori, Mauro Magnani, Gina Lisignoli, Katia Scotlandi
Engagement of CD99 activates distinct programs in Ewing sarcoma and macrophages. Cancer immunology research (2023)
Federica Scotto di Carlo, Sharon Russo, Francesc Muyas, Maria Mangini, Lorenza Garribba, Laura Pazzaglia, Rita Genesio, Flavia Biamonte, Anna Chiara De Luca, Stefano Santaguida, Katia Scotlandi, Isidro Cortes-Ciriano, Fernando Gianfrancesco
Profilin 1 deficiency drives mitotic defects and reduces genome stability. Communications biology 6 (1) (2023)
Claudia Maria Hattinger, Iris Chiara Salaroglio, Leonardo Fantoni, Martina Godel, Chiara Casotti, Joanna Kopecka, Katia Scotlandi, Toni Ibrahim, Chiara Riganti, Massimo Serra
Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma. International journal of molecular sciences 24 (1) (2023)
Federica Scotto di Carlo, Sharon Russo, Francesc Muyas, Maria Mangini, Lorenza Garribba, Laura Pazzaglia, Rita Genesio, Flavia Biamonte, Anna Chiara De Luca, Stefano Santaguida, Katia Scotlandi, Isidro Cortes-Ciriano, Fernando Gianfrancesco
Profilin 1 deficiency drives mitotic defects and reduces genome stability. Communications biology 6 (1) (2023)
Lorena Landuzzi, Francesca Ruzzi, Pier-Luigi Lollini, Katia Scotlandi
Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research. Cancers 15 (3) (2023)
Federica Scotto di Carlo, Sharon Russo, Francesc Muyas, Maria Mangini, Lorenza Garribba, Laura Pazzaglia, Rita Genesio, Flavia Biamonte, Anna Chiara De Luca, Stefano Santaguida, Katia Scotlandi, Isidro Cortes-Ciriano, Fernando Gianfrancesco
Profilin 1 deficiency drives mitotic defects and reduces genome stability. Communications biology 6 (1) (2023)
Sara Salucci, Alberto Bavelloni, Anna Bartoletti Stella, Francesco Fabbri, Ivan Vannini, Manuela Piazzi, Karyna Volkava, Katia Scotlandi, Giovanni Martinelli, Irene Faenza, William L Blalock
The Cytotoxic Effect of Curcumin in Rhabdomyosarcoma Is Associated with the Modulation of AMPK, AKT/mTOR, STAT, and p53 Signaling. Nutrients 15 (3) (2023)
Federica Scotto di Carlo, Sharon Russo, Francesc Muyas, Maria Mangini, Lorenza Garribba, Laura Pazzaglia, Rita Genesio, Flavia Biamonte, Anna Chiara De Luca, Stefano Santaguida, Katia Scotlandi, Isidro Cortes-Ciriano, Fernando Gianfrancesco
Profilin 1 deficiency drives mitotic defects and reduces genome stability. Communications biology 6 (1) (2023)
Claudia Maria Hattinger, Iris Chiara Salaroglio, Leonardo Fantoni, Martina Godel, Chiara Casotti, Joanna Kopecka, Katia Scotlandi, Toni Ibrahim, Chiara Riganti, Massimo Serra
Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma. International journal of molecular sciences 24 (1) (2023)
Federica Scotto di Carlo, Sharon Russo, Francesc Muyas, Maria Mangini, Lorenza Garribba, Laura Pazzaglia, Rita Genesio, Flavia Biamonte, Anna Chiara De Luca, Stefano Santaguida, Katia Scotlandi, Isidro Cortes-Ciriano, Fernando Gianfrancesco
Profilin 1 deficiency drives mitotic defects and reduces genome stability. Communications biology 6 (1) (2023)
Lorena Landuzzi, Maria Cristina Manara, Laura Pazzaglia, Pier-Luigi Lollini, Katia Scotlandi
Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma. Cancers 15 (15) (2023)
Lorena Landuzzi, Francesca Ruzzi, Pier-Luigi Lollini, Katia Scotlandi
Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research. Cancers 15 (3) (2023)
Sukanya Chakraborty, Aaqib M Bhat, Insha Mushtaq, Haitao Luan, Achyuth Kalluchi, Sameer Mirza, Matthew D Storck, Nagendra K Chaturvedi, Jose Antonio Lopez-Guerrero, Antonio Llombart-Bosch, Isidro Machado, Katia Scotlandi, Jane L Meza, Gargi Ghosal, Donald W Coulter, M Jordan Rowley, Vimla Band, Bhopal C Mohapatra, Hamid Band
EHD1-dependent traffic of IGF-1 receptor to the cell surface is essential for Ewing sarcoma tumorigenesis and metastasis. Communications biology 6 (1) (2023)
Caterina Mancarella, Veronica Giusti, Giulia Caldoni, Maria Antonella Laginestra, Alessandro Parra, Lisa Toracchio, Giorgia Giordano, Laura Roncuzzi, Manuela Piazzi, William L Blalock, Marta Columbaro, Alessandra De Feo, Katia Scotlandi
Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells. Cancer gene therapy (2023)
Caterina Mancarella, Andrea Morrione, Katia Scotlandi
PROTAC-Based Protein Degradation as a Promising Strategy for Targeted Therapy in Sarcomas. International journal of molecular sciences 24 (22) (2023)
Claudia Maria Hattinger, Iris Chiara Salaroglio, Leonardo Fantoni, Martina Godel, Chiara Casotti, Joanna Kopecka, Katia Scotlandi, Toni Ibrahim, Chiara Riganti, Massimo Serra
Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma. International journal of molecular sciences 24 (1) (2023)
Teresa González Muñoz, Angela Di Giannatale, Susana Garcia-Silva, Vanesa Santos, Sara Sanchez-Redondo, Claudia Savini, Osvaldo Graña-Castro, Carmen Blanco-Aparicio, Suzanne Fischer, Olivier De Wever, Edgar Creus-Bachiller, Sara Ortega-Bertran, David J Pisapia, José Luis Rodríguez-Peralto, Juana Fernández-Rodríguez, Cleofe Romagosa, Rita Alaggio, Maria Serena Benassi, Laura Pazzaglia, Katia Scotlandi, Nancy Ratner, Kaleb Yohay, Charles P Theuer, Hector Peinado
Endoglin, a novel biomarker and therapeutical target to prevent malignant peripheral nerve sheath tumor growth and metastasis. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Sara Salucci, Alberto Bavelloni, Anna Bartoletti Stella, Francesco Fabbri, Ivan Vannini, Manuela Piazzi, Karyna Volkava, Katia Scotlandi, Giovanni Martinelli, Irene Faenza, William L Blalock
The Cytotoxic Effect of Curcumin in Rhabdomyosarcoma Is Associated with the Modulation of AMPK, AKT/mTOR, STAT, and p53 Signaling. Nutrients 15 (3) (2023)
Michela Pasello, Anna Maria Giudice, Camilla Cristalli, Maria Cristina Manara, Caterina Mancarella, Alessandro Parra, Massimo Serra, Giovanna Magagnoli, Florencia Cidre-Aranaz, Thomas G P Grünewald, Carla Bini, Pier-Luigi Lollini, Alessandra Longhi, Davide Maria Donati, Katia Scotlandi
Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis. Cellular oncology (Dordrecht) (2022)
Caterina Mancarella, Marianna Carrabotta, Lisa Toracchio, Katia Scotlandi
CIC-Rearranged Sarcomas: An Intriguing Entity That May Lead the Way to the Comprehension of More Common Cancers. Cancers 14 (21) (2022)
Evelin Pellegrini, Giovanna Desando, Mauro Petretta, Antonella Cellamare, Camilla Cristalli, Michela Pasello, Maria Cristina Manara, Brunella Grigolo, Katia Scotlandi
A 3D Collagen-Based Bioprinted Model to Study Osteosarcoma Invasiveness and Drug Response. Polymers 14 (19) (2022)
Marianna Carrabotta, Maria Antonella Laginestra, Giorgio Durante, Caterina Mancarella, Lorena Landuzzi, Alessandro Parra, Francesca Ruzzi, Lisa Toracchio, Alessandra De Feo, Veronica Giusti, Michela Pasello, Alberto Righi, Pier-Luigi Lollini, Emanuela Palmerini, Davide Maria Donati, Maria Cristina Manara, Katia Scotlandi
Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma. Cancer research 82 (4) (2022)
Michela Pasello, Anna Maria Giudice, Camilla Cristalli, Maria Cristina Manara, Caterina Mancarella, Alessandro Parra, Massimo Serra, Giovanna Magagnoli, Florencia Cidre-Aranaz, Thomas G P Grünewald, Carla Bini, Pier-Luigi Lollini, Alessandra Longhi, Davide Maria Donati, Katia Scotlandi
ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis. Cellular oncology (Dordrecht) (2022)
Manuela Piazzi, Alberto Bavelloni, Vittoria Cenni, Sara Salucci, Anna Bartoletti Stella, Enrica Tomassini, Katia Scotlandi, William L Blalock, Irene Faenza
Combined Treatment with PI3K Inhibitors BYL-719 and CAL-101 Is a Promising Antiproliferative Strategy in Human Rhabdomyosarcoma Cells. Molecules (Basel, Switzerland) 27 (9) (2022)
Francesca Chiarini, Francesca Paganelli, Tommaso Balestra, Cristina Capanni, Antonietta Fazio, Maria Cristina Manara, Lorena Landuzzi, Stefania Petrini, Camilla Evangelisti, Pier-Luigi Lollini, Alberto M Martelli, Giovanna Lattanzi, Katia Scotlandi
Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma. Cell death & disease 13 (4) (2022)
Alessandra De Feo, Laura Pazzaglia, Lisa Ciuffarin, Fabio Mangiagli, Michela Pasello, Elisa Simonetti, Evelin Pellegrini, Cristina Ferrari, Giuseppe Bianchi, Benedetta Spazzoli, Katia Scotlandi
miR-214-3p Is Commonly Downregulated by EWS-FLI1 and by CD99 and Its Restoration Limits Ewing Sarcoma Aggressiveness. Cancers 14 (7) (2022)
Emanuela Palmerini, Laura Pazzaglia, Luca Cevolani, Loredana Pratelli, Michela Pierini, Irene Quattrini, Elisa Carretta, Maria Cristina Manara, Michela Pasello, Giorgio Frega, Anna Paioli, Alessandra Longhi, Marilena Cesari, Rossella Hakim, Toni Ibrahim, Laura Campanacci, Eric Lodewijk Staals, Davide Maria Donati, Maria Serena Benassi, Katia Scotlandi, Stefano Ferrari
Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative Study. Cancers 14 (12) (2022)
Claudia Maria Hattinger, Chiara Casotti, Maria Pia Patrizio, Silvia Luppi, Leonardo Fantoni, Katia Scotlandi, Toni Ibrahim, Massimo Serra
Pharmacogenomic Profiling of Cisplatin-Resistant and -Sensitive Human Osteosarcoma Cell Lines by Multimodal Targeted Next Generation Sequencing. International journal of molecular sciences 23 (19) (2022)
Michele Minopoli, Sabrina Sarno, Lucia Cannella, Salvatore Tafuto, Giosuè Scognamiglio, Michele Gallo, Flavio Fazioli, Rosa Azzaro, Gaetano Apice, Biagio De Angelis, Elena Tamborini, Cecilia Garofalo, Ymera Pignochino, Laura Mercatali, Toni Ibrahim, Rita Falcioni, Beatrice Valenti, Roberta Maestro, Katia Scotlandi, Annarosaria De Chiara, Maria Vincenza Carriero
Crosstalk between Macrophages and Myxoid Liposarcoma Cells Increases Spreading and Invasiveness of Tumor Cells. Cancers 13 (13) (2021)
Giuseppe Bianchi, Debora Lana, Marco Gambarotti, Cristina Ferrari, Marta Sbaraglia, Elena Pedrini, Laura Pazzaglia, Luca Sangiorgi, Isabella Bartolotti, Angelo Paolo Dei Tos, Katia Scotlandi, Alberto Righi
Clinical, Histological, and Molecular Features of Solitary Fibrous Tumor of Bone: A Single Institution Retrospective Review. Cancers 13 (10) (2021)
Leonardo Leonardi, Katia Scotlandi, Ilaria Pettinari, Maria Serena Benassi, Ilaria Porcellato, Laura Pazzaglia
MiRNAs in Canine and Human Osteosarcoma: A Highlight Review on Comparative Biomolecular Aspects. Cells 10 (2) (2021)
Caterina Mancarella, Andrea Morrione, Katia Scotlandi
Unraveling the IGF System Interactome in Sarcomas Exploits Novel Therapeutic Options. Cells 10 (8) (2021)
Daniel José García-Domínguez, Nabil Hajji, Sara Sánchez-Molina, Elisabet Figuerola-Bou, Rocío M de Pablos, Ana M Espinosa-Oliva, Eduardo Andrés León, Laura Carmen Terrón-Camero, Rocío Flores-Campos, Guillem Pascual-Pasto, María José Robles, Isidro Machado, Antonio Llombart-Bosch, Giovanna Magagnoli, Katia Scotlandi, Angel Montero Carcaboso, Jaume Catala-Mora, Enrique de Álava, Lourdes Hontecillas-Prieto
Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma. Oncogene 40 (39) (2021)
Caterina Mancarella, Andrea Morrione, Katia Scotlandi
Novel Regulators of the IGF System in Cancer. Biomolecules 11 (2) (2021)
Georgia Zoumpoulidou, Carlos Alvarez-Mendoza, Caterina Mancusi, Ritika-Mahmuda Ahmed, Milly Denman, Christopher D Steele, Maxime Tarabichi, Errin Roy, Lauren R Davies, Jiten Manji, Camilla Cristalli, Katia Scotlandi, Nischalan Pillay, Sandra J Strauss, Sibylle Mittnacht
Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcoma. Nature communications 12 (1) (2021)
Tommaso Balestra, Maria Cristina Manara, Maria Antonella Laginestra, Michela Pasello, Alessandra De Feo, Cristian Bassi, Clara Guerzoni, Lorena Landuzzi, Pier-Luigi Lollini, Davide Maria Donati, Massimo Negrini, Mauro Magnani, Katia Scotlandi
Targeting CD99 Compromises the Oncogenic Effects of the Chimera EWS-FLI1 by Inducing Reexpression of Zyxin and Inhibition of GLI1 Activity. Molecular cancer therapeutics (2021)
Lorena Landuzzi, Maria Cristina Manara, Pier-Luigi Lollini, Katia Scotlandi
Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma. Cells 10 (2) (2021)
Katia Scotlandi, Claudia Maria Hattinger, Evelin Pellegrini, Marco Gambarotti, Massimo Serra
Genomics and Therapeutic Vulnerabilities of Primary Bone Tumors. Cells 9 (4) (2020)
Marika Sciandra, Alessandra De Feo, Alessandro Parra, Lorena Landuzzi, Pier-Luigi Lollini, Maria Cristina Manara, Gianfranco Mattia, Giada Pontecorvi, Cristina Baricordi, Clara Guerzoni, Alberto Bazzocchi, Alessandra Longhi, Katia Scotlandi
Circulating miR34a levels as a potential biomarker in the follow-up of Ewing sarcoma. Journal of cell communication and signaling 14 (3) (2020)
Michele Minopoli, Sabrina Sarno, Gioconda Di Carluccio, Rosa Azzaro, Susan Costantini, Flavio Fazioli, Michele Gallo, Gaetano Apice, Lucia Cannella, Domenica Rea, Maria Patrizia Stoppelli, Diana Boraschi, Alfredo Budillon, Katia Scotlandi, Annarosaria De Chiara, Maria Vincenza Carriero
Inhibiting Monocyte Recruitment to Prevent the Pro-Tumoral Activity of Tumor-Associated Macrophages in Chondrosarcoma. Cells 9 (4) (2020)
Michela Pasello, Maria Cristina Manara, Katia Scotlandi
CD99 at the crossroads of physiology and pathology. Journal of cell communication and signaling 12 (1) (2018)
Maria Eugénia Marques da Costa, Estelle Daudigeos-Dubus, Anne Gomez-Brouchet, Olivia Bawa, Valérie Rouffiac, Massimo Serra, Katia Scotlandi, Conceição Santos, Didier Frappaz, Nathalie Gaspar
Establishment and characterization of in vivo orthotopic bioluminescent xenograft models from human osteosarcoma cell lines in Swiss nude and NSG mice. Cancer medicine 7 (3) (2018)

Katia Scotlandi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Katia Scotlandi